Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece.
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
The U.S.-listed shares of Novo Nordisk A.S. were plunging toward their worst day in decades on Friday after the results from ...
Novo Nordisk Stock: A Rare Buying Opportunity
Financial writer sees Novo Nordisk's stock drop as a buying opportunity after disappointing trial results, citing strong ...
Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
Novo Nordisk, Europe’s largest company by market value, faced a stock market bloodbath on Friday after disappointing results ...
Novo Nordisk Stock Crashes on Obesity Drug Data. It’s a Win for Eli Lilly.
Novo Nordisk has told the world it expects patients to lose “at least 25%” of their body weight on its experimental drug CagriSema. On Friday, Novo released the results of a large Phase 3 trial of the ...
Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results
Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...
Novo Nordisk shares head for worst day since the 1980s
Shares of Ozempic-maker Novo Nordisk were down more than 20% in recent trade as the Danish drugmaker headed for its worst day since the 1980s. The stock took a hit after a late-stage trial showed that ...
Novo Nordisk Crashes On Worse Than Expected Obesity Data (Rating Upgrade)
Novo Nordisk's CargiSema Phase III trial showed significant weight loss but failed reach ambitious targets set by management.
Nasdaq3d
Novo Nordisk's Options Frenzy: What You Need to Know
Investors with a lot of money to spend have taken a bullish stance on Novo Nordisk (NYSE:NVO). And retail traders should know. We noticed this today when the trades showed up on publicly available ...